Varied Growth Drivers Led Antipodes Global Value Strategy to Add Globus Medical (GMED) to Its Portfolio
Antipodes Partners recently published its “Antipodes Global Value Strategy” third-quarter 2025 investor letter, highlighting the key performance stocks, portfolio changes, and the market outlook.







